Item Type | Name |
Concept
|
Schizophrenia
|
Academic Article
|
Elevated levels of plasma phenylalanine in schizophrenia: a guanosine triphosphate cyclohydrolase-1 metabolic pathway abnormality?
|
Academic Article
|
The interplay between BDNF and oxidative stress in chronic schizophrenia.
|
Academic Article
|
Decreased interleukin-10 serum levels in first-episode drug-na?ve schizophrenia: relationship to psychopathology.
|
Academic Article
|
Elevated Plasma S100B, Psychotic Symptoms, and Cognition in Schizophrenia.
|
Academic Article
|
Impact of synthetic cannabinoid use on hospital stay in patients with bipolar disorder versus schizophrenia, or other psychotic disorders.
|
Academic Article
|
Toxoplasma gondii antibody titers and history of suicide attempts in patients with schizophrenia.
|
Academic Article
|
Elevated gliadin antibody levels in individuals with schizophrenia.
|
Academic Article
|
In patients with schizophrenia, non-fatal suicidal self-directed violence is positively associated with present but not past smoking.
|
Academic Article
|
6R-l-erythro-5,6,7,8-tetrahydrobiopterin (BH4): a potential treatment for all symptom domains of schizophrenia.
|
Academic Article
|
Accelerated aging in schizophrenia patients: the potential role of oxidative stress.
|
Academic Article
|
Hospital length of stay in individuals with schizophrenia with and without cocaine-positive urine drug screens at hospital admission.
|
Academic Article
|
Phadiatop Seropositivity in Schizophrenia Patients and Controls: A Preliminary Study.
|
Academic Article
|
Cocaine use in individuals with schizophrenia: impact on doses of discharge antipsychotic medications.
|
Academic Article
|
Combined Toxoplasma gondii seropositivity and high blood kynurenine--Linked with nonfatal suicidal self-directed violence in patients with schizophrenia.
|
Academic Article
|
A Study of the Impact of Cannabis on Doses of Discharge Antipsychotic Medication in Individuals with Schizophrenia or Schizoaffective Disorder.
|
Academic Article
|
Kynurenine and Tryptophan Levels in Patients With Schizophrenia and Elevated Antigliadin Immunoglobulin G Antibodies.
|
Academic Article
|
Blood Levels of Monoamine Precursors and Smoking in Patients with Schizophrenia.
|
Academic Article
|
Plasma soluble L-selectin in medicated patients with schizophrenia and healthy controls.
|
Academic Article
|
C-Reactive Protein Correlates with Negative Symptoms in Patients with Schizophrenia.
|
Academic Article
|
Trajectory of brain maturation and sex-specific cognitive abnormalities in early-onset psychosis.
|
Academic Article
|
Ethnic differences in the diagnosis of schizophrenia and mood disorders during admission to an academic safety-net psychiatric hospital.
|
Academic Article
|
Correlations between Body Mass Index, Plasma High-Sensitivity C-Reactive Protein and Lipids in Patients with Schizophrenia.
|
Academic Article
|
Hospital Stay in Synthetic Cannabinoid Users With Bipolar Disorder, Schizophrenia, or Other Psychotic Disorders Compared With Cannabis Users.
|
Academic Article
|
Plasma soluble P-selectin correlates with triglycerides and nitrite in overweight/obese patients with schizophrenia.
|
Academic Article
|
Repetitive Transcranial Magnetic Stimulation: A Potential Treatment for Obesity in Patients with Schizophrenia.
|
Academic Article
|
Clozapine Is Associated With Higher COVID-19 Infection Rate in Veterans With Schizophrenia or Schizoaffective Disorder.
|
Academic Article
|
Plasma Soluble P-selectin, Interleukin-6 and S100B Protein in Patients with Schizophrenia: a Pilot Study.
|
Academic Article
|
History of Suicide Attempts and COVID-19 Infection in Veterans with Schizophrenia or Schizoaffective Disorder: Moderating Effects of Age and Body Mass Index.
|
Academic Article
|
History of Suicide Attempt and Clozapine Treatment in Veterans With Schizophrenia or Schizoaffective Disorder.
|
Academic Article
|
Challenges and Considerations in Treating Negative and Cognitive Symptoms of Schizophrenia Spectrum Disorders.
|